Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichiro Kanda

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Iscience|November 28, 2022
Urinary extracellular vesicles signature for diagnosis of kidney diseaseKeiichi Takizawa, Koji Ueda, Masahiro Sekiguchi, et al.
Journal of Human Genetics|March 4, 2018
Clinically diverse phenotypes and genotypes of patients with branchio-oto-renal syndromeAi Unzaki, Naoya Morisada, Kandai Nozu, et al.
Clinical and Experimental Nephrology|May 28, 2019
Clinical characteristics of HNF1B-related disorders in a Japanese populationChina Nagano, Naoya Morisada, Kandai Nozu, et al.
Nature Communications|June 4, 2020
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5Tomohiko Yamamura, Tomoko Horinouchi, Tomomi Adachi, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Iscience|November 28, 2022
Urinary extracellular vesicles signature for diagnosis of kidney diseaseKeiichi Takizawa, Koji Ueda, Masahiro Sekiguchi, et al.
Journal of Human Genetics|March 4, 2018
Clinically diverse phenotypes and genotypes of patients with branchio-oto-renal syndromeAi Unzaki, Naoya Morisada, Kandai Nozu, et al.
Clinical and Experimental Nephrology|May 28, 2019
Clinical characteristics of HNF1B-related disorders in a Japanese populationChina Nagano, Naoya Morisada, Kandai Nozu, et al.
Nature Communications|June 4, 2020
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5Tomohiko Yamamura, Tomoko Horinouchi, Tomomi Adachi, et al.
Pageof 5